COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma

Berking, Carola; Livingstone, Elisabeth; Debus, Dirk; Loquai, Carmen; Weichenthal, Michael; Leiter, Ulrike; Kiecker, Felix; Mohr, Peter; Eigentler, Thomas K.; Remy, Janina; Schober, Katharina; Heppt, Markus V.; von Wasielewski, Imke; Schadendorf, Dirk; Gutzmer, Ralf

dc.contributor.author	Leiter-Stöppke, Ulrike
dc.date.accessioned	2024-05-28T06:01:29Z
dc.date.available	2024-05-28T06:01:29Z
dc.date.issued	2023
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/153735
dc.language.iso	en	de_DE
dc.publisher	Basel : Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers15184436	de_DE
dc.subject.ddc	610	de_DE
dc.title	COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240124000000_01312
utue.personen.roh	Berking, Carola
utue.personen.roh	Livingstone, Elisabeth
utue.personen.roh	Debus, Dirk
utue.personen.roh	Loquai, Carmen
utue.personen.roh	Weichenthal, Michael
utue.personen.roh	Leiter, Ulrike
utue.personen.roh	Kiecker, Felix
utue.personen.roh	Mohr, Peter
utue.personen.roh	Eigentler, Thomas K.
utue.personen.roh	Remy, Janina
utue.personen.roh	Schober, Katharina
utue.personen.roh	Heppt, Markus V.
utue.personen.roh	von Wasielewski, Imke
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Gutzmer, Ralf
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 4436	de_DE
dcterms.isPartOf.ZS-Volume	15 (18)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE